BRANDYWINE MANAGERS, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 104 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
BRANDYWINE MANAGERS, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$116,004
+34.5%
26,1270.0%0.20%
+243.9%
Q2 2023$86,219
+15.8%
26,1270.0%0.06%
+7.5%
Q1 2023$74,462
-60.9%
26,1270.0%0.05%
-92.0%
Q4 2022$190,205
-9.9%
26,1270.0%0.66%
-4.2%
Q3 2022$211,000
+64.8%
26,1270.0%0.69%
+121.0%
Q2 2022$128,000
-79.3%
26,1270.0%0.31%
-70.5%
Q1 2022$618,000
+38.3%
26,127
+3.4%
1.07%
+110.7%
Q4 2021$447,000
-22.3%
25,280
+24.0%
0.51%
-15.7%
Q3 2021$575,000
+168.7%
20,3880.0%0.60%
+145.9%
Q2 2021$214,000
-10.8%
20,3880.0%0.24%
-23.5%
Q1 2021$240,000
+0.4%
20,3880.0%0.32%
-3.0%
Q4 2020$239,000
+47.5%
20,3880.0%0.33%
+7.2%
Q3 2020$162,000
-42.3%
20,388
+32.5%
0.31%
-73.4%
Q2 2020$281,000
+52.7%
15,3880.0%1.15%
+1675.4%
Q1 2020$184,000
-2.6%
15,388
+35.1%
0.06%
+14.0%
Q4 2019$189,000
-4.1%
11,388
-61.7%
0.06%
-13.6%
Q3 2019$197,00029,7000.07%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders